Westfield Capital Management Company, L.P. has reported beneficial ownership of 3,016,026 shares of Bicycle Therapeutics plc common stock, representing 6.04% of the class as of 12/31/2025.
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Westfield Capital Management Company, L.P. has reported beneficial ownership of 3,016,026 shares of Bicycle Therapeutics plc common stock, representing 6.04% of the class as of 12/31/2025.
Westfield has sole power to vote 2,801,276 shares and sole power to dispose of 3,016,026 shares, with no shared voting or dispositive power. The shares are owned of record by Westfield’s investment advisory clients, who are entitled to dividends and sale proceeds. Westfield states the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of the company.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
BICYCLE THERAPEUTICS PLC
(Name of Issuer)
Common Stock
(Title of Class of Securities)
088786108
(CUSIP Number)
12/31/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
088786108
1
Names of Reporting Persons
Westfield Capital Management Company, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
MASSACHUSETTS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
2,801,276.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
3,016,026.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
3,016,026.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.04 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
BICYCLE THERAPEUTICS PLC
(b)
Address of issuer's principal executive offices:
BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, UNITED KINGDOM
CB21 6GS
Item 2.
(a)
Name of person filing:
Westfield Capital Management Company, L.P.
(b)
Address or principal business office or, if none, residence:
1 Financial Center, 24th Floor
Boston, Massachusetts
02111
(c)
Citizenship:
Westfield Capital Management Company, L.P. - MASSACHUSETTS
(d)
Title of class of securities:
Common Stock
(e)
CUSIP No.:
088786108
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
3,016,026
(b)
Percent of class:
6.04 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Westfield Capital Management Company, L.P. - 2,801,276
(ii) Shared power to vote or to direct the vote:
Westfield Capital Management Company, L.P. - 0
(iii) Sole power to dispose or to direct the disposition of:
Westfield Capital Management Company, L.P. - 3,016,026
(iv) Shared power to dispose or to direct the disposition of:
Westfield Capital Management Company, L.P. - 0
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
The shares of the security listed in this Schedule are owned of record by clients of Westfield Capital Management
Company, L.P. (Westfield) in its capacity as investment adviser. Westfield's clients have the right to receive, or the power
to direct the receipt of, dividends or proceeds from the sale of the shares. To the best of Westfield's knowledge, no client
has such right or power with respect to more than five percent of this class of security.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
